Sign in to continue:

Tuesday, February 10th, 2026

Mapletree Pan Asia Commercial Trust (MPACT) 2025 Outlook: Stable Distributions, Strong Singapore Performance, and Attractive Dividend Yield

Broker Name: Maybank Research Pte Ltd
Date of Report: October 24, 2025

Excerpt from Maybank Research Pte Ltd report.

Report Summary

  • Mapletree Pan Asia Commercial Trust (MPACT) reported a stable 2Q FY26 with DPU up 1.5% YoY, led by strong performance from VivoCity, margin improvements, and lower finance costs.
  • Revenue and net property income declined mainly due to Japan asset divestments and adverse FX, but lower utilities and borrowing costs cushioned the impact.
  • Occupancy remained high at 88.9%, with improvements in Singapore offsetting some weakness in Japan and Greater China; rental reversions were flat overall.
  • Gearing was stable at 37.6%, and proactive capital management, including gradual repricing of swaps and portfolio optimisation, is a continued focus.
  • FY26 DPU forecast was raised by 1.2% due to better margins and lower borrowing costs; target price was increased to SGD1.55 with a maintained BUY rating.
  • Risks include weaker rental reversions in Hong Kong, slower retail sales in Singapore, and higher interest costs as hedges reprice.
  • MPACT benefits from diversified exposure in five Asian markets, with a strong Singapore base and support from Temasek’s Mapletree Investments.
  • Environmental, social, and governance (ESG) initiatives are emphasized, with energy savings, green loans, high board independence, and gender diversity.
  • Valuations are seen as fair (5.4% yield, 0.8x PB), and Singapore’s resilience is expected to underpin stable distributions despite overseas headwinds.

above is an excerpt from a report by Maybank Research Pte Ltd. Clients of Maybank Research Pte Ltd can be the first to access the full report from the Maybank Research Pte Ltd website : www.maybank.com/investment-banking

Singapore Exchange (SGX) Q2 2025 Results: Cash Equities Drive Growth, Market Review Ongoing

In-Depth Financial Analysis of Leading Stock Exchanges In-Depth Financial Analysis of Leading Stock Exchanges Broker: CGS International Date: February 6, 2025 Singapore Exchange (SGX) Singapore Exchange (SGX) demonstrated robust performance in 1HFY6/25, reporting a...

Singapore & Asia Equity Income Fund: Top Yield Stocks & REITs, TSMC Earnings Beat, and Regional Income Playbook 1

Broker Name: DBS Date of Report: Inferred – Not explicitly stated in the document Excerpt from DBS report: JPMorgan Asset Management launched the Singapore & Asia Equity Income Fund, targeting a 50% allocation to...

iX Biopharma Ltd Bullish Reversal: Technical Buy Signals & Market Insights – Singapore Retail Research September 2025

CGS International Securities Singapore Pte. Ltd. Date of Report: September 26, 2025 Bullish Reversal for iX Biopharma & China Market Trends: September 2025 Retail Research Deep Dive Market Recap: Shifting Tides in Chinese Bonds...